Table 2 Evolution of blood cells count values between baseline and 12 weeks (G/L)
| Blood cells | Evolution between baseline and 12 weeks | p* | |
|---|---|---|---|
|
PMBL® tablet N = 21 Mean ± SD |
Placebo N = 28 Mean ± SD | ||
| Total red blood cells | − 0.02 ± 0.27 | + 0.06 ± 0.29 | 0.4178 |
| Total white blood cells | + 0.4 ± 1.51 | + 0.13 ± 3.53 | 0.9046 |
| Neutrophils (% WBC) | + 0.27 ± 1.28 (+ 1.1 ± 9.6) | + 0.33 ± 2.53 (+ 3.9 ± 9.7) | 0.4697 (0.1727) |
| Basophils (% WBC) | − 0.00 ± 0.02 (− 0.06 ± 0.24) | 0.00 ± 0.01 (+ 0.01 ± 0.29) | 0.9838 (0.6610) |
| Eosinophils (% WBC) | + 0.01 ± 0.21 (− 0.3 ± 3.6) | + 0.06 ± 0.27 (0.5 ± 3.7) | 0.8243 (0.8507) |
| Lymphocytes (% WBC) | + 0.12 ± 0.49 (− − 0.2 ± 7.6) | − 0.30 ± 0.86 (− 5.2 ± 8.5) | 0.0141 (0.1339) |
| Monocytes (% WBC) | + 0.01 ± 0.21 (− 0.7 ± 2.3) | + 0.04 ± 0.57 (0.7 ± 2.5) | 0.5564 (0.5102) |
| Platelet count | + 0.7 ± 38.2 | − 13.2 ± 45.3 | 0.2621 |